These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Rebound hypersecretion after inhibition of gastric acid secretion. Qvigstad G; Waldum H Basic Clin Pharmacol Toxicol; 2004 May; 94(5):202-8. PubMed ID: 15125689 [TBL] [Abstract][Full Text] [Related]
7. [Antacids and H2 antihistaminics for hyperacidity]. Wegat T; Metzmann K; Leuner K; Müller WE Pharm Unserer Zeit; 2007; 36(1):44-51. PubMed ID: 17283750 [No Abstract] [Full Text] [Related]
8. Acid suppression: how much is needed? Colin-Jones DG BMJ; 1990 Sep; 301(6752):564-5. PubMed ID: 1978697 [No Abstract] [Full Text] [Related]
9. Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthrough. Pan T; Wang Y; Guo Z; Wang Q Cochrane Database Syst Rev; 2004 Oct; (4):CD004275. PubMed ID: 15495095 [TBL] [Abstract][Full Text] [Related]
10. Preanaesthetic H2 antagonists for acid aspiration pneumonia prophylaxis. Is there evidence of tolerance? Hirota K; Kushikata T Br J Anaesth; 2003 May; 90(5):576-9. PubMed ID: 12697583 [No Abstract] [Full Text] [Related]
11. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade. Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465 [TBL] [Abstract][Full Text] [Related]
12. Do H2 receptor antagonists have to be given at night? A study of the antisecretory profile of SKF 94482, a new H2 receptor antagonist which has a profound effect on daytime acidity. Chiverton SG; Burget DW; Hunt RH Gut; 1989 May; 30(5):594-9. PubMed ID: 2567265 [TBL] [Abstract][Full Text] [Related]
13. Twenty-four-hour intragastric pH-metry: H2-receptor antagonist restoration of nightly gastric spontaneous alkalinization in duodenal ulcer healing. Bianco A; Cagossi M; Piraccini R; Greco AV Riv Eur Sci Med Farmacol; 1992; 14(5):281-91. PubMed ID: 1364062 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Maton PN; Gardner JD; Jensen RT Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602 [TBL] [Abstract][Full Text] [Related]
15. [Movement of gastric acid secretion and influence of proton pump inhibitors on histamine H2 receptor antagonist resistant ulcer]. Asaki S; Kimpara T; Ohara S; Hongo M Nihon Rinsho; 1992 Jan; 50(1):111-5. PubMed ID: 1347323 [TBL] [Abstract][Full Text] [Related]
16. Acid inhibition and the acid rebound effect. Lerotić I; Baršić N; Stojsavljević S; Duvnjak M Dig Dis; 2011; 29(5):482-6. PubMed ID: 22095014 [TBL] [Abstract][Full Text] [Related]
17. Histamine H2-receptor antagonists. Keithley JK Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461 [TBL] [Abstract][Full Text] [Related]
18. [Management of the hypersecretion of acid in Zollinger-Ellison syndrome (ZES)]. Varas MJ; López A; Gordillo J Rev Esp Enferm Apar Dig; 1989 Apr; 75(4):419-20. PubMed ID: 2568007 [No Abstract] [Full Text] [Related]
19. Is an intravenous histamine H2 receptor antagonist superior to an intravenous proton pump inhibitor in acid suppression? Kinoshita Y; Ishihara S J Gastroenterol; 2004 Jan; 39(1):92-3. PubMed ID: 14767746 [No Abstract] [Full Text] [Related]